Human papillomavirus (HPV) is the most common sexually transmitted infection among Americans and although it can be prevented with a vaccine, only 60% of girls and 50% of boys in the U.S, had started the HPV vaccine series as of 2016. Left untreated, HPV can cause cervical, head, and neck cancers among other health complications.…
Our team just got a little bigger! We would like to introduce our newest team member, Ponni Anand, M.Sc., MBA, who will be joining us as a Research Services Manager. Ponni has a diverse background in clinical research, strategic planning, and project management. She has earned an M.Sc. in Medical Biochemistry, an M.Sc. in Biology,…
In a recent interview with KIRO 7, Gary Gilliard, president of Fred Hutchinson Cancer Research Center in Seattle, talked about the success they are having with CAR T cell immunotherapies for some metastatic cancers. The Hutch has long been a leader in immunotherapy research and has made many lifesaving discoveries harnessing the power of the…
In the last few years, CAR T cell-based immunotherapies have shown great promise in clinical trials, and scientists are continuing to advance their knowledge with hopes of developing CAR T cell therapies for a range of cancers. CAR T cells are designed to essentially function as antigen-specific T cells, which can be difficult to collect…